176 related articles for article (PubMed ID: 9674632)
1. Angiotensin-converting enzyme inhibition, but not calcium antagonism, improves a response of the renal vasculature to L-arginine in patients with essential hypertension.
Higashi Y; Oshima T; Sasaki S; Nakano Y; Kambe M; Matsuura H; Kajiyama G
Hypertension; 1998 Jul; 32(1):16-24. PubMed ID: 9674632
[TBL] [Abstract][Full Text] [Related]
2. Severity of hypertension affects improved resistance artery endothelial function by angiotensin-converting enzyme inhibition.
Higashi Y; Sasaki S; Nakagawa K; Kimura M; Sasaki S; Noma K; Hara K; Matsuura H; Goto C; Oshima T; Chayama K
J Cardiovasc Pharmacol; 2002 May; 39(5):668-76. PubMed ID: 11973410
[TBL] [Abstract][Full Text] [Related]
3. Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
Higashi Y; Sasaki S; Nakagawa K; Matsuura H; Kajiyama G; Oshima T
J Am Coll Cardiol; 2001 Mar; 37(3):863-70. PubMed ID: 11693763
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension.
On YK; Kim CH; Oh BH; Lee MM; Park YB
Hypertens Res; 2002 May; 25(3):365-71. PubMed ID: 12135314
[TBL] [Abstract][Full Text] [Related]
5. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension.
van der Does R; Euler R
J Int Med Res; 2001; 29(3):154-62. PubMed ID: 11471852
[TBL] [Abstract][Full Text] [Related]
8. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
9. Improvement of endothelial function by amlodipine and vitamin C in essential hypertension.
On YK; Kim CH; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Korean J Intern Med; 2002 Jun; 17(2):131-7. PubMed ID: 12164090
[TBL] [Abstract][Full Text] [Related]
10. Effects of vasodilatory antihypertensive agents on endothelial dysfunction in rats with ischemic acute renal failure.
Kakoki M; Hirata Y; Hayakawa H; Suzuki E; Nagata D; Nishimatsu H; Kimura K; Goto A; Omata M
Hypertens Res; 2000 Sep; 23(5):527-33. PubMed ID: 11016809
[TBL] [Abstract][Full Text] [Related]
11. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
[TBL] [Abstract][Full Text] [Related]
13. Comparison of renal and vascular protective effects between telmisartan and amlodipine in hypertensive patients with chronic kidney disease with mild renal insufficiency.
Nakamura T; Inoue T; Suzuki T; Kawagoe Y; Ueda Y; Koide H; Node K
Hypertens Res; 2008 May; 31(5):841-50. PubMed ID: 18712038
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil augments the beneficial hemodynamic and histopathological effects of amlodipine in nitric oxide-deficient hypertensive rats: role of nitric oxide-cyclic GMP pathway.
Aboutabl ME; Raafat M; Maklad YA; Kenawy SA; El Din AG
Pharmacol Res; 2008 Jun; 57(6):456-63. PubMed ID: 18572415
[TBL] [Abstract][Full Text] [Related]
15. The effects of amlodipine and S(-)-amlodipine on vascular endothelial function in patients with hypertension.
He Y; Si D; Yang C; Ni L; Li B; Ding M; Yang P
Am J Hypertens; 2014 Jan; 27(1):27-31. PubMed ID: 23959544
[TBL] [Abstract][Full Text] [Related]
16. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
Morimoto S; Yano Y; Maki K; Iwasaka T
J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
[TBL] [Abstract][Full Text] [Related]
17. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
Ruilope LM; Schaefer A
Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
[TBL] [Abstract][Full Text] [Related]
20. Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect.
Watanabe Y; Takasugi E; Shitakura K; Okajima K; Hota N; Kubo Y; Nunoda S; Otsuka K
Clin Exp Hypertens; 2011; 33(4):246-54. PubMed ID: 21699451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
